Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial

Authors : Branch KRH, Dagenais GR, Avezum A, Basile J, Conget I, Cushman WC, Jansky P, Lakshmanan M, Lanas F, Leiter LA, *Pais P*, Pogosova N, Raubenheimer PJ, Ryden L, Shaw JE, Sheu WHH, Temelkova-Kurktschiev T, Bethe MA, Gerstein HC, Chinthanie R & Probstfiel JL.

Publication Year : 2022

Abstract :

https://pubmed.ncbi.nlm.nih.gov/36073143/